Georgetown Lombardi Survivorship Research Initiative Seminar Series: “Cancer Predisposition in the Genomic Era: Consideration for Cancer Survivors”
The Georgetown Lombardi Survivorship Research Initiative works to optimize cancer survivorship across the lifespan and ensure equity for patients of every race, ethnicity, gender and socially determined status. This seminar series invites scientists from Georgetown and outside institutions to present their research. It also provides a forum in which individuals may present work in progress to receive meaningful feedback from a multidisciplinary audience.
Sharon Plon, MD, PhD
Dan L. Duncan Comprehensive Cancer Center Professorship, Departments of Pediatrics and Molecular and Human Genetics
Assistant Dean, School of Medicine
Baylor College of Medicine
“Cancer Predisposition in the Genomic Era: Consideration for Cancer Survivors”
Meet the Speaker:
Dr. Plon will speak from 10 – 11 a.m. Immediately following the SRI seminar, there will be a 30-minute Meet the Professor session, which will provide attendees an opportunity to engage in Q&A and discuss specific research subjects with Dr. Plon.
About the Speaker:
Dr. Sharon Plon is a board-certified medical geneticist and a longstanding cancer genetics researcher identifying new cancer susceptibility genes and studying the implementation of genomic testing in medicine. Dr. Plon holds the Dan L Duncan Comprehensive Cancer Center Professorship at Baylor College of Medicine in the Departments of Pediatrics and Molecular and Human Genetics and a member of the Human Genome Sequencing Center. Dr. Plon also serves as Assistant Dean in the School of Medicine at Baylor College of Medicine. Dr. Plon serves as Principal Investigator with Donald (Will) Parsons and Amy McGuire on the NHGRI/NCI-U01 Texas KidsCanSeq multi-institutional trial that studies the incorporation of CLIA clinical genome-scale exome sequencing into the care of childhood cancer patients in the diverse patient populations in Texas. Since 2013, Dr. Plon has served as one of the Principal Investigators of the Clinical Genome (ClinGen) Resource and co-chairs the ClinGen Hereditary Cancer Clinical Domain. She also currently co-chairs the germline reporting effort of the national NCI/COG Pediatric MATCH Precision Oncology trial. Dr. Plon is a prior member of the American Society of Human Genetics Board of Directors and the NIH-National Advisory Council for Human Genome Research. She is a member of the 5th Edition Tumour Genetics Volume Editorial Board.